OXIPRA 20 LA SOLUTION FOR INJECTION

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Aktīvā sastāvdaļa:

OXYTETRACYCLINE (AS OXYTETRACYCLINE DIHYDRATE PH. EUR.)

Pieejams no:

Laboratorios Hipra S.A.

ATĶ kods:

QJ01AA06

SNN (starptautisko nepatentēto nosaukumu):

OXYTETRACYCLINE (AS OXYTETRACYCLINE DIHYDRATE PH. EUR.)

Deva:

200 Mg/Ml

Zāļu forma:

Solution for Injection

Receptes veids:

POM: Prescription Only Medicine as defined in relevant national legislation

Ārstniecības grupa:

Bovine, Ovine, Porcine

Ārstniecības joma:

oxytetracycline

Ārstēšanas norādes:

Antibacterial

Autorizācija statuss:

Authorised

Autorizācija datums:

2006-04-03

Produkta apraksts

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Oxipra 20 L.A. Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, sheep and swine.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Indicated for the treatment of infections caused by sensitive germs in
cattle, sheep and swine: anaplasmosis, respiratory
infection, keratoconjunctivitis and metritis, mastitis and aglactia
(MMA) syndrome.
4.3 CONTRAINDICATIONS
- Do not use in animals which are sensitive to tetracyclines.
- Do not use in animals which have liver or kidney disorders.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each ml contains:
ACTIVE SUBSTANCE
Oxytetracycline (as oxytetracycline dihydrate) 200 mg
EXCIPIENTS
Sodium Formaldehyde Sulfoxylate
10
mg
N,N-Dimethylacetamide
467 mg
For a full list of excipients, see section 6.1
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_7_
_/_
_1_
_0_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_5_
_1_
_1_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not administer more than 10 ml at the injection site.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
None.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Intramuscular injection may be painful, producing swelling at the
injection site.
In s